ARCHIVES

Talking Back: FDA Faces Challenges Over Avastin & Prostate Cancer Prevention

This article is from The Cancer Letter archive.

Vol. 37 No. 03 | January 21, 2011

Download PDF Visit The Full Archive

Related Articles

Two-Month Longer Survival Found With Gliadel Wafer

March 31, 2006

FDA Continues Bureaucratic Delays Of Cancer INDs

January 30, 1976

The Clinical Trials Working Group: NCI panel considers plan to centralize clinical trial review and prioritization. NCI director faults system for duplication, “equivocal results.”

August 13, 2004

House Committee Investigates Marketing Practices Of Amgen And J&J For ESAs.

April 4, 2008

RFAs available: Chemoprevention Clinical Trials

July 22, 1994

Studies Shed Light On Racial Disparities Between Blacks, Whites With Breast Cancer

July 31, 2009